Abstract
The cell-mediated immunity (CMI) of 47 critically ill surgical patients admitted to an Intensive Therapy Unit was assessed by their response to recall skin antigens and found to be markedly reduced. Thirty-seven patients showed no reaction to initial skin testing (NR), and there were 21 deaths in this group. Ten patients reacted (R) to initial skin testing and only one of these patients died (p less than 0.025). Repeat skin testing was performed on 22 NR patients. Eight became R on repeat testing and there was one death in this group, whilst 14 remained NR and there were 11 deaths in this group (p less than 0.025). The major clinical difference between R and NR patients was a greater incidence of severe sepsis in the NR patients. These findings suggest that the use of recall skin antigens to assess CMI may be a valuable investigation in critically ill surgical patients and that initial and persisting failure to react to skin tests is associated with a poor outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.